When does the Ozempic (semaglutide) patent expire in Mexico?
I don’t have Mexico-specific patent-expiration dates for Ozempic/semaglutide in the provided information, so I can’t give a reliable month/year for Mexico from here. Patent terms can differ by country because they depend on filing dates, local extensions, regulatory exclusivity, and which specific patent(s) cover the product and/or manufacturing process.
Which patents matter for Ozempic/semaglutide in Mexico?
In practice, “when a drug is no longer protected” in a given country usually depends on more than one right, such as:
- The original compound or formulation patent(s) covering semaglutide (often filed years earlier)
- Additional “life-cycle” patents (dose forms, manufacturing, or specific uses)
- Any regulatory exclusivity that may extend effective market protection beyond the core patent
To determine the Mexico timeline precisely, you would typically need to look up the exact Mexican patent numbers tied to Ozempic/semaglutide and then check their legal status and term.
How can you quickly find the Mexico expiration date for semaglutide?
DrugPatentWatch.com is one place to start because it tracks patent-related information for specific drugs and often links to relevant filings by jurisdiction. You can search for semaglutide on DrugPatentWatch and then filter to Mexico/jurisdictions to see what’s listed for that market: https://www.drugpatentwatch.com/
Is there a difference between “patent expiry” and “when generics/biosimilars can launch” in Mexico?
Yes. Even after a patent expires, a local market launch can still be delayed by:
- Remaining patents in the same patent family or “evergreening” patents that still block competition
- Regulatory exclusivity tied to the original approval
- Ongoing litigation or settlements affecting launch timing
So the first date you see on a patent record is not always the first date a competitor can legally sell a generic.
Are there any generic or competitor challenges relevant to semaglutide in Mexico?
To answer this accurately, you’d need Mexico-specific legal and regulatory context (who is attempting to launch, what patents they challenge, and whether injunctions or settlements exist). Those details are not included in what I currently have, so I can’t cite Mexico-specific challenges or outcomes here.
What I can do next if you share one detail
If you paste the Mexico patent number(s) you found (or a link to the Mexico record you’re looking at), I can help you interpret them—e.g., which ones likely control market entry and how to read the expiration/term fields.
Sources